Alfons van BlaaderenChristina ChristovaMirjam E. LeunissenC. Patrick RoyallAntti‐Pekka HynninenMarjolein Dijkstra
A range of hematologic causes need to be considered when evaluating anemia in the presence of treatment with a C5 inhibitor.
Mirjam E. LeunissenChristina ChristovaAntti‐Pekka HynninenC. Patrick RoyallAndrew I. CampbellArnout ImhofMarjolein DijkstraRené van RoijAlfons van Blaaderen
Wei LinMotoyoshi KobayashiMichal SkarbaChangdao MuPaolo GallettoMichal Borkovec
Emily R. RussellJoris SprakelThomas E. KodgerDavid A. Weitz
Antonio M. PuertasA. Fernández-BarberoF. J. de las Nieves